Skip to main content

Asbestos and Mesothelioma

  • Book
  • © 2017

Overview

  • Disseminates for the first time information from a study demonstrating that inherited mutations can influence a person’s risk of mesothelioma
  • Addresses the fact that, besides mesothelioma, some of the BAP1 mutation carriers developed ocular melanoma or other cancers, and this cancer susceptibility is now recognized as the BAP1 Syndrome
  • Highlights will be the various molecular signaling pathways that are hyper-activated in this disease, facilitating the identification of novel druggable targets for cancer therapy or prevention
  • Includes supplementary material: sn.pub/extras

Part of the book series: Current Cancer Research (CUCR)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (18 chapters)

Keywords

About this book

This volume is comprised of a multidisciplinary assessment of the interplay between asbestos and cancer as well as new research about the biology and treatment of malignant mesothelioma.  Chapters on the various types of asbestos and other mineral fibers, epidemiology, history and future of asbestos-related diseases are included.  Other reviews present new information about the role of asbestos-related inflammation and genetic factors, including the role of inherited mutations of BAP1, in mesothelioma causation, as well as recent research about gene signatures, cell signaling, and epigenetic mechanisms in asbestos-related diseases.  Other chapters provide updates of novel disease biomarkers and prevention, mechanistic lesson from genetically engineered mouse and 3-D models of mesothelioma tumorigenesis and therapeutic resistance.  Also included are up-to-date reviews of surgical, molecularly targeted chemotherapeutic, and immunotherapeutic approaches for mesothelioma as well as an overview of legal issues.

Editors and Affiliations

  • Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, USA

    Joseph R. Testa

About the editor

Joseph R. Testa, PhD, FACMG is Senior Member/Professor, Carol and Kenneth E. Weg Chair in Human Genetics, Chief of Laboratory Genetics, and Co-Leader of the Cancer Biology Program at Fox Chase Cancer Center, Philadelphia, PA. His research interests focus on mesothelioma pathogenesis and AKT-related oncogenesis. He has published numerous papers and reviews, and serves on the editorial boards of several journals, including as Senior Editor for Cancer Research. He has received multiple science awards, including the J. Christopher Wagner Medal from the International Mesothelioma Interest Group and the Pioneer Research Award from the Mesothelioma Applied Research Foundation. He is also a Fellow of the American Association for the Advancement of Science.

Bibliographic Information

  • Book Title: Asbestos and Mesothelioma

  • Editors: Joseph R. Testa

  • Series Title: Current Cancer Research

  • DOI: https://doi.org/10.1007/978-3-319-53560-9

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer International Publishing AG 2017

  • Hardcover ISBN: 978-3-319-53558-6Published: 18 April 2017

  • Softcover ISBN: 978-3-319-85183-9Published: 08 August 2018

  • eBook ISBN: 978-3-319-53560-9Published: 06 April 2017

  • Series ISSN: 2199-2584

  • Series E-ISSN: 2199-2592

  • Edition Number: 1

  • Number of Pages: VIII, 407

  • Number of Illustrations: 22 b/w illustrations, 43 illustrations in colour

  • Topics: Cancer Research

Publish with us